AAPL   324.63 (-0.15%)
MSFT   185.43 (+0.04%)
FB   231.12 (+0.42%)
GOOGL   1,439.58 (+0.02%)
AMZN   2,502.54 (+0.97%)
NVDA   351.95 (+0.33%)
CGC   16.43 (-0.85%)
MU   49.29 (+0.76%)
ACB   14.11 (-1.33%)
F   6.26 (+1.13%)
DIS   122.66 (+0.39%)
BAC   25.89 (-0.38%)
BA   180.75 (+4.38%)
AAPL   324.63 (-0.15%)
MSFT   185.43 (+0.04%)
FB   231.12 (+0.42%)
GOOGL   1,439.58 (+0.02%)
AMZN   2,502.54 (+0.97%)
NVDA   351.95 (+0.33%)
CGC   16.43 (-0.85%)
MU   49.29 (+0.76%)
ACB   14.11 (-1.33%)
F   6.26 (+1.13%)
DIS   122.66 (+0.39%)
BAC   25.89 (-0.38%)
BA   180.75 (+4.38%)
AAPL   324.63 (-0.15%)
MSFT   185.43 (+0.04%)
FB   231.12 (+0.42%)
GOOGL   1,439.58 (+0.02%)
AMZN   2,502.54 (+0.97%)
NVDA   351.95 (+0.33%)
CGC   16.43 (-0.85%)
MU   49.29 (+0.76%)
ACB   14.11 (-1.33%)
F   6.26 (+1.13%)
DIS   122.66 (+0.39%)
BAC   25.89 (-0.38%)
BA   180.75 (+4.38%)
AAPL   324.63 (-0.15%)
MSFT   185.43 (+0.04%)
FB   231.12 (+0.42%)
GOOGL   1,439.58 (+0.02%)
AMZN   2,502.54 (+0.97%)
NVDA   351.95 (+0.33%)
CGC   16.43 (-0.85%)
MU   49.29 (+0.76%)
ACB   14.11 (-1.33%)
F   6.26 (+1.13%)
DIS   122.66 (+0.39%)
BAC   25.89 (-0.38%)
BA   180.75 (+4.38%)
Log in

ASX:VHTVolpara Health Tech Stock Price, Forecast & News

A$1.33
-0.02 (-1.48 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$1.32
Now: A$1.33
A$1.36
50-Day Range
A$1.07
MA: A$1.31
A$1.54
52-Week Range
A$0.79
Now: A$1.33
A$2.17
Volume434,964 shs
Average VolumeN/A
Market Capitalization$290.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueA$0.08 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$290.02 million
Next Earnings DateN/A
OptionableOptionable

Receive VHT News and Ratings via Email

Sign-up to receive the latest news and ratings for VHT and its competitors with MarketBeat's FREE daily newsletter.

Volpara Health Tech (ASX:VHT) Frequently Asked Questions

How has Volpara Health Tech's stock been impacted by COVID-19 (Coronavirus)?

Volpara Health Tech's stock was trading at A$1.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VHT shares have increased by 16.7% and is now trading at A$1.33. View which stocks have been most impacted by Coronavirus.

Has Volpara Health Tech been receiving favorable news coverage?

Media stories about VHT stock have been trending somewhat negative this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Volpara Health Tech earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutVolpara Health Tech.

Who are some of Volpara Health Tech's key competitors?

What other stocks do shareholders of Volpara Health Tech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Volpara Health Tech investors own include Sabre Resources (SBR), Webjet (WEB), South32 (S32), Nearmap (NEA), Aristocrat Leisure (ALL) and Auscann Group (AC8).

Who are Volpara Health Tech's key executives?

Volpara Health Tech's management team includes the following people:
  • Dr. Ralph Highnam, CEO, Chief Scientist, Exec. Director & Member of Scientific Board
  • Mr. Craig Hadfield, CFO & Joint Company Sec.
  • Mr. David Murray Ph.D., Chief Technology Officer
  • Mr. Mark Koeniguer, Chief Commercial Officer & Pres of USA
  • Mr. Julian Marshall, Chief Product Officer

What is Volpara Health Tech's stock symbol?

Volpara Health Tech trades on the ASX under the ticker symbol "VHT."

What is Volpara Health Tech's stock price today?

One share of VHT stock can currently be purchased for approximately A$1.33.

How big of a company is Volpara Health Tech?

Volpara Health Tech has a market capitalization of $290.02 million.

What is Volpara Health Tech's official website?

The official website for Volpara Health Tech is volparasolutions.com.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.